BioNexus Gene Lab Corp's total assets for Q2 2026 were $8.73M, a decrease of -58.84% from the previous quarter. BGLC total liabilities were $947.98K for the fiscal quarter, a -92.77% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.